Selected article for: "lopinavir ritonavir and lung strategy"
Author: Guqin Zhang; Chang Hu; Linjie Luo; Fang Fang; Yongfeng Chen; Jianguo Li; Zhiyong Peng; Huaqin Pan
Title: Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China
  • Document date: 2020_3_6
    • ID: jir7n19b_8
    Snippet: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.02.20030452 doi: medRxiv preprint oseltamivir, arbidol hydrochloride, α-interferon atomization inhalation, and lopinavir/ritonavir), (4) Extracorporeal membrane oxygenation (ECMO) support was used for the patients with refractory hypoxemia that is difficult to be corrected by prone and protective lung ventilation strategy......
    Document: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.02.20030452 doi: medRxiv preprint oseltamivir, arbidol hydrochloride, α-interferon atomization inhalation, and lopinavir/ritonavir), (4) Extracorporeal membrane oxygenation (ECMO) support was used for the patients with refractory hypoxemia that is difficult to be corrected by prone and protective lung ventilation strategy.

    Search related documents:
    Co phrase search for related documents
    • arbidol hydrochloride and membrane oxygenation: 1
    • atomization inhalation and interferon atomization inhalation: 1, 2
    • ECMO extracorporeal membrane oxygenation and extracorporeal membrane oxygenation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ECMO extracorporeal membrane oxygenation and lung ventilation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ECMO extracorporeal membrane oxygenation and lung ventilation strategy: 1, 2, 3
    • ECMO extracorporeal membrane oxygenation and membrane oxygenation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ECMO extracorporeal membrane oxygenation and refractory hypoxemia: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ECMO extracorporeal membrane oxygenation and refractory hypoxemia patient: 1
    • ECMO extracorporeal membrane oxygenation support and extracorporeal membrane oxygenation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ECMO extracorporeal membrane oxygenation support and lung ventilation: 1, 2
    • ECMO extracorporeal membrane oxygenation support and membrane oxygenation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ECMO extracorporeal membrane oxygenation support and refractory hypoxemia: 1, 2, 3, 4
    • extracorporeal membrane oxygenation and lung ventilation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • extracorporeal membrane oxygenation and lung ventilation strategy: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • extracorporeal membrane oxygenation and membrane oxygenation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • extracorporeal membrane oxygenation and protective prone lung ventilation strategy: 1
    • extracorporeal membrane oxygenation and refractory hypoxemia: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • extracorporeal membrane oxygenation and refractory hypoxemia patient: 1, 2
    • lung ventilation and membrane oxygenation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25